Unigene Laboratories Inc

Formerly OTC: UGNEQ

Credit Agreements Filter

EX-10.1
from 10-Q 19 pages Senior Secured Convertible Note
12/34/56
EX-10.20
from 10-K 2 pages December 22, 2008 Dr. Ronald S. Levy Executive Vice President Unigene Laboratories, Inc. 81 Fulton Street Boonton, Nj 07005 Re: Amendment to Nonqualified Deferred Compensation Agreement Dear Ron, Reference Is Made to the Nonqualified Deferred Compensation Agreement (The “Deferred Compensation Agreement”) Dated February 1, 2006, by and Between You and Unigene Laboratories, Inc. (The “Company”). by Signing This Letter Agreement, You and the Company, Intending to Be Legally Bound, Hereby Amend the Deferred Compensation Agreement as Follows, Effective December 31, 2008: The Paragraph of the Deferred Compensation Agreement Entitled “Acceleration of Annual Credits” Is Hereby Amended and Restated in Its Entirety, to Read as Follows
12/34/56
EX-10.19
from 10-K 2 pages December 19, 2008 Dr. Warren P. Levy President & Chief Executive Officer Unigene Laboratories, Inc. 81 Fulton Street Boonton, Nj 07005 Re: Amendment to Nonqualified Deferred Compensation Agreement Dear Warren, Reference Is Made to the Nonqualified Deferred Compensation Agreement (The “Deferred Compensation Agreement”) Dated February 1, 2006, by and Between You and Unigene Laboratories, Inc. (The “Company”). by Signing This Letter Agreement, You and the Company, Intending to Be Legally Bound, Hereby Amend the Deferred Compensation Agreement as Follows, Effective December 31, 2008: The Paragraph of the Deferred Compensation Agreement Entitled “Acceleration of Annual Credits” Is Hereby Amended and Restated in Its Entirety, to Read as Follows
12/34/56